The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Wealth building investment strategies can empower beginners to grow their finances. Explore effective approaches to start investing wisely.
21,485 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Global defense budgets are expanding, driving gains in aerospace and defense equities. The ITA ETF offers access to a...
China is pivoting from selling finished goods to supplying key components for assembly abroad, fueling Southeast Asia...
A data center hardware maker saw a dramatic stock drop this week amid regulatory and supply chain concerns. This guid...
Insiders are loading up Arbor Realty Trust while bears keep a large short position. The clash over who’s right Arbor ...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
Micron shares slid about 4% in early trading even after the company posted a robust quarterly report and raised its f...
FuboTV's reverse stock split reduces outstanding Class A and Class B shares, triggering a debate among retail investo...
A single insider sale coincided with a sharp move lower in Sprinklr’s shares, prompting questions about signal versus...
Goldman Sachs upgrades Verizon with a higher price target as the carrier commits to a new reporting framework and ong...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
A seasoned investor warns that the global financial system faces a new kind of threat: capital shifts driven by debt,...